|
Multiple sclerosis
Citations 101-110 of 469 total displayed.
|
Past content
(since Jan 2001):
|
- REFLECTIONS: NEUROLOGY AND THE HUMANITIES
Ferris Wheels, Fly Fishing, and the Dumping
- Michael John Doherty
Neurology 2008; 71: 2015-2017.
[Full text]
[PDF]
- ARTICLES
Multiple sclerosis and the TNFRSF1A R92Q mutation: Clinical characteristics of 21 cases
- T. Kümpfel, L-A Hoffmann, H. Pellkofer, W. Pöllmann, W. Feneberg, R. Hohlfeld, and P. Lohse
Neurology 2008; 71: 1812-1820.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Cognitive impairment and structural brain damage in benign multiple sclerosis
- M. Rovaris, G. Riccitelli, E. Judica, F. Possa, D. Caputo, A. Ghezzi, A. Bertolotto, R. Capra, M. Falautano, F. Mattioli, V. Martinelli, G. Comi, and M. Filippi
Neurology 2008; 71: 1521-1526.
[Abstract]
[Full text]
[PDF]
- PATIENT PAGES
Are "statins" beneficial or harmful in multiple sclerosis?
- Christopher Lock
Neurology 2008; 71: e54-56e.
[Full text]
[PDF]
- EDITORIALS
Statins to treat multiple sclerosis: Friend or foe?
- Myla D. Goldman and Jeffrey A. Cohen
Neurology 2008; 71: 1386-1387.
[Full text]
[PDF]
- ARTICLES
Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis
- G. Birnbaum, B. Cree, I. Altafullah, M. Zinser, and A. T. Reder
Neurology 2008; 71: 1390-1395.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis
- M. Krumbholz, I. Meinl, T. Kümpfel, R. Hohlfeld, and E. Meinl
Neurology 2008; 71: 1350-1354.
[Abstract]
[Full text]
[PDF]
- ARTICLES
FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis
- M. Mehling, V. Brinkmann, J. Antel, A. Bar-Or, N. Goebels, C. Vedrine, C. Kristofic, J. Kuhle, R.L.P. Lindberg, and L. Kappos
Neurology 2008; 71: 1261-1267.
[Abstract]
[Full text]
[PDF]
- EDITORIALS
Cross-reactivity between epidemiology and immunology in multiple sclerosis
- Amit Bar-Or and Jack Antel
Neurology 2008; 71: 1132-1133.
[Full text]
[PDF]
- ARTICLES
Dose comparison trial of sustained-release fampridine in multiple sclerosis
- A. D. Goodman, T. R. Brown, J. A. Cohen, L. B. Krupp, R. Schapiro, S. R. Schwid, R. Cohen, L. N. Marinucci, A. R. Blight For the Fampridine MS-F202 Study Group
Neurology 2008; 71: 1134-1141.
[Abstract]
[Full text]
[PDF]
|
|
